Article

Optos founder receives life sciences award

Dunfermline, Scotland—Scottish Enterprise, which honors companies and individuals in Scotland who contribute to the global life sciences community, has honored Optos Inc. founder Douglas Anderson.

Dunfermline, Scotland-Scottish Enterprise, which honors companies and individuals in Scotland who contribute to the global life sciences community, has honored Optos Inc. founder Douglas Anderson.

Anderson, who also serves as executive vice chairman of the retinal imaging company, received the 2004 Scottish Life Sciences Award for a Leading Individual Contribution.

Anderson worked to develop the Optomap retinal exam in 1992, which is used in 1,600 practices throughout the world. The technology was developed after Anderson's 5-year-old son was left blind in one eye when a retinal detachment was detected too late.

The company is based in Dunfermline with North American headquarters in Marlborough, MA.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
© 2025 MJH Life Sciences

All rights reserved.